CODY HARRIS: Open Payments
NPI 1992081467 · LEWISTON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 39 payments from 7 companies in 2025. Trend: 2023 $350 · 2024 $933 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $210 |
| GlaxoSmithKline, LLC. | 18 | $169 |
| PFIZER INC. | 3 | $57 |
| Abbott Laboratories | 3 | $50 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: TRELEGY ELLIPTA, UBRELVY, QULIPTA, NURTEC ODT, FREESTYLE LIBRE 3, Auvelity, Ozempic, VRAYLAR.
Industry payments across ID — which companies pay providers there.
